Bupleurum Entangled QI Formula
En vente sur le marché américain (selon le DSLD)
Health Concerns, food supplement from the US market
Bupleurum Entangled QI Formula (Health Concerns), a food supplement without a usable barcode in DSLD, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Conditions légales
Trichosanthes kirilowii Maxim.: L'absence de trichosanthine doit être prouvée par des rapports d'analyse.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Health Concerns
- Barcode
- Not provided or invalid in DSLD
- Form
- Tablet
- One serving
- 3 tablets
- Servings
- number of servings per day not stated
- Other ingredients (in English, as written)
- Vegetable Gum, Silicon Dioxide, Stearic Acid, Cellulose
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Blend | Blend | 750 mg |
| Bupleurum | Plant | not stated |
| Tang Kuei (Angelica sinensis) | Plant | not stated |
| Blue Citrus | Plant | not stated |
| Prunella (Prunella vulgaris) | Plant | not stated |
| Salvia | Plant | not stated |
| Trichosanthes (Trichosanthes kirilowii) | Plant | not stated |
| Vaccaria | Plant | not stated |
| White Peony (Paeonia lactiflora) | Plant | not stated |
| Cyperus | Plant | not stated |
| Ligusticum | Plant | not stated |
| Fritillaria | Plant | not stated |
| Taraxacum | Plant | not stated |
| Zhi shi (Citrus aurantium) | Plant | not stated |
| Red Peony | Plant | not stated |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Bupleurum Entangled QI Formula
Entered into DSLD on 25 June 2013. Retirée du marché américain le 21 March 2017 (selon le DSLD).- Active ingredient added : Proprietary Blend (Herb/Botanical) (2,250 mg)
- Active ingredient removed : Proprietary Blend (750 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Tang Kuei
Read the warning, when it applies and the studies cited
DONG QUAI - ANGELICA SINENSIS
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (NS 2021).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking any medications including blood thinners, birth control pills or hormone therapy (NS 2021; Brinker 2010; WHO 2002).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have serious or major conditions, any type of acute infection, deficiency or excess (HC 2022).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid exposure to the sun (NS 2021; Thorne 2004).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Do not use if you are pregnant (NS 2021; WHO 2002).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Do not use if you have diarrhea, hemorrhagic diseases or heavy periods (NS 2021, Bensky et al. 2004; Chen and Chen 2004; WHO 2002).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen, or if new symptoms develop such as breast pain or any changes in menstrual cycles (Brinker 2010; Schumacher et al. 2007; Thorne 2004; Russell et al. 2002).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
- Prunella
Read the warning, when it applies and the studies cited
HEAL-ALL - PRUNELLA VULGARIS - Buccal and Oromucosal
Route of administration: Buccal Oromuccosal
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 February 2026
HEAL-ALL - PRUNELLA VULGARIS - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 February 2026
HEAL-ALL - PRUNELLA VULGARIS - Topical
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Applies to products for use on minor skin wounds/irritations.
Do not use on deep or puncture wounds, animal bites or serious burns.
Known adverse reactions
Applies to products for use on hemorrhoids.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience bleeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Health Concerns
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.